Drugs / Lansoprazole 15 mg
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04784910 Comparator | May 2021 → Nov 2023 | peptic ulcer disease | Daewoong Pharmaceutical Co. LTD. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lansoprazole 15 mg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04784910 ↗ |
| Route | Oral | “orally, once daily” NCT04784910 ↗ |